These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 5982666)
1. [Thalidomide embryopathy in animal experiments. 3. Teratologic tests of thalidomide catabolic products]. Heine W Z Kinderheilkd; 1966; 96(2):141-6. PubMed ID: 5982666 [No Abstract] [Full Text] [Related]
2. [Synthesis and teratologic examination of various thalidomide metabolites]. Meise W; Köhler F Pharmazie; 1972 Jun; 27(6):418-9. PubMed ID: 5082274 [No Abstract] [Full Text] [Related]
3. AN ATTEMPTED REVERSAL OF THALIDOMIDE EMBRYOPATHY IN THE RAT BY GLUTAMINE. MCCOLL JD; GLOBUS M; ROBINSON S Can J Physiol Pharmacol; 1965 Jan; 43():69-73. PubMed ID: 14324233 [No Abstract] [Full Text] [Related]
5. Thalidomide. A study of biochemical teratology. Williams RT Arch Environ Health; 1968 Apr; 16(4):493-502. PubMed ID: 5690102 [No Abstract] [Full Text] [Related]
6. [THALIDOMIDE EMBRYOPATHY IN ANIMAL EXPERIMENT. REPRODUCTION OF THE THALIDOMIDE EMBRYOPATHY IN A TERATOLOGIC EXPERIMENT IN RABBITS WITH TRANSIENT LIVER DAMAGE]. HEINE W; KIRCHMAIR H; FIEDLER M; STUEWE W Z Kinderheilkd; 1964 Nov; 91():213-21. PubMed ID: 14333485 [No Abstract] [Full Text] [Related]
7. EFFECTS OF THALIDOMIDE ON PREGNANCY IN THE RABBIT. HAY MF J Reprod Fertil; 1964 Aug; 8():59-76. PubMed ID: 14195708 [No Abstract] [Full Text] [Related]
8. Relationship between teratogeny and structure in the thalidomide field. Wuest HM; Fox RR; Crary DD Experientia; 1968 Oct; 24(10):993-4. PubMed ID: 5751867 [No Abstract] [Full Text] [Related]
9. [Abnormalities of internal organs in thalidomide embryopathy. A contribution to the determination of the sensitivity phase in thalidomide administration during early pregnancy]. Kreipe U Arch Kinderheilkd; 1967 Aug; 176(1):33-61. PubMed ID: 5595238 [No Abstract] [Full Text] [Related]
10. [Thalidomide embryopathy. V. Kidney malformations]. Hauke H; Weicker H Dtsch Med Wochenschr; 1965 Dec; 90(49):2200-4. PubMed ID: 5843508 [No Abstract] [Full Text] [Related]
15. [Embryotoxic acitivity of N-phthaloyl-DL-isoglutamine]. Meise W; Köhler F Z Naturforsch B; 1971 Oct; 26(10):1081-2. PubMed ID: 4401638 [No Abstract] [Full Text] [Related]
16. [Cephalometric findings in dysmelic children with symptoms of thalidomide embryopathy]. Stahl A Dtsch Zahnarztl Z; 1968 Apr; 23(4):520-1. PubMed ID: 5240539 [No Abstract] [Full Text] [Related]
17. The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species. Schumacher H; Smith RL; Williams RT Br J Pharmacol Chemother; 1965 Oct; 25(2):338-51. PubMed ID: 5866716 [No Abstract] [Full Text] [Related]
18. [The so-called dysmelia syndrome (Thalidomide embryopathy) and its differential diagnosis]. Weicker H Wien Med Wochenschr; 1967 Apr; 117(15):387-90. PubMed ID: 5627596 [No Abstract] [Full Text] [Related]
19. [Thalidomide embryopathy in Japan]. Kida M; Lenz W Arch Kinderheilkd; 1968 Sep; 177(3):244-59. PubMed ID: 5716213 [No Abstract] [Full Text] [Related]
20. The teratogenic activity of thalidomide in the rabbit. Fabro S; Smith RL J Pathol Bacteriol; 1966 Apr; 91(2):511-9. PubMed ID: 4958643 [No Abstract] [Full Text] [Related] [Next] [New Search]